Co SE (KCO:GR) with a Buy rating and a price target of EUR8.10. The firm's analysts highlight the company's strategic shift towards more promising opportunities in North America and the ...
Kepler Cheuvreux downgraded Valerio Therapeutics shares from Hold to Reduce, significantly lowering the price target to EUR0.01 from EUR0.10. The downgrade follows the company's announcement of a ...
Kepler Capital analyst Jon Cox maintained a Buy rating on Dufry AG (0QK3 – Research Report) on February 6 and set a price target of CHF50.00.